Discover
PMVP
PMV Pharmaceuticals, Inc.
1.24
2 x 0.96
2 x 1.54
bid
ask
-
0.10
7.46%
2 @ 04:00 PM
1.25 +0.01 (0.81%)
| Ytd | -0.80% | |
| 1y | 18.10% |
1.20
day range
1.34
1.02
52 week range
1.88
| Open | 1.34 | Prev Close | 1.34 | Low | 1.20 | High | 1.34 | Mkt Cap | 66.13M |
| Vol | 253.82K | Avg Vol | 368.46K | EPS | -1.48 | P/E | N/A | Forward P/E | -0.96 |
| Beta | 1.48 | Short Ratio | 5.17 | Inst. Own | 83.89% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-13 | 50-d Avg | 1.26 | 200-d Avg | 1.30 | 1yr Est | 5.80 |
| Income Statement | |||
| Operating Expenses | 19.02M | ||
| Research and Development Expense | 15.33M | ||
| Selling, General and Administrative Expense | 3.69M | ||
| Operating Income | -19.02M | ||
| Net Income | -18.04M | ||
| Net Income Common Stock | -18.04M | ||
| Net Income Common Stock (USD) | -18.04M | ||
| Consolidated Income | -18.04M | ||
| Earnings per Basic Share | -0.34 | ||
| Earnings per Basic Share (USD) | -0.34 | ||
| Earnings per Diluted Share | -0.34 | ||
| Earning Before Interest & Taxes (EBIT) | -18.04M | ||
| Earning Before Interest & Taxes (USD) | -18.04M | ||
| Weighted Average Shares | 53.33M | ||
| Weighted Average Shares Diluted | 53.33M | ||
| Balance Sheet | |||
| Cash and Equivalents | 39.13M | ||
| Cash and Equivalents (USD) | 39.13M | ||
| Investments | 54.42M | ||
| Investments Current | 54.42M | ||
| Current Assets | 95.78M | ||
| Property, Plant & Equipment Net | 486.00K | ||
| Total Assets | 96.56M | ||
| Debt Current | 293.00K | ||
| Total Debt | 293.00K | ||
| Current Liabilities | 8.60M | ||
| Total Liabilities | 8.60M | ||
| Accumulated Retained Earnings (Deficit) | -464.49M | ||
| Accumulated Other Comprehensive Income | -15.00K | ||
| Shareholders Equity | 87.97M | ||
| Shareholders Equity (USD) | 87.97M | ||
| Assets Non-Current | 782.00K | ||
| Total Debt (USD) | 293.00K | ||
| Trade and Non-Trade Payables | 1.63M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 34.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 1.15M | ||
| Net Cash Flow from Investing | 20.82M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 20.82M | ||
| Net Cash Flow from Operations | -19.68M | ||
| Effect of Exchange Rate Changes on Cash | 2.00K | ||
| Share Based Compensation | 1.39M | ||